Ovid Therapeutics Inc. (OVID): Shares Outstanding

Annual figures by period end, from SEC filings.

130.18M
As of 2025-12-31
184.76M
As of 2026-06-30
+22.7%
3-year compound annual growth
+14.6%
5-year compound annual growth
2016-12-31: 9.84M2017-12-31: 24.61M2018-12-31: 24.65M2019-12-31: 54.71M2020-12-31: 65.74M2021-12-31: 70.36M2022-12-31: 70.47M2023-12-31: 70.69M2024-12-31: 71.01M2025-12-31: 130.18M130.18M
2016-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-31130.18M+83.3%2026-03-18, Balance as of period end
2024-12-3171.01M+0.4%2026-03-18, Balance as of period end
2023-12-3170.69M+0.3%2025-03-11, Balance as of period end
2022-12-3170.47M+0.1%2024-03-08, Balance as of period end
2021-12-3170.36M+7.0%2023-03-13, Balance as of period end
2020-12-3165.74M+20.2%2022-03-15, Balance as of period end
2019-12-3154.71M+121.9%2021-03-15, Balance as of period end
2018-12-3124.65M+0.2%2020-03-11, Balance as of period end
2017-12-3124.61M+150.1%2019-03-07, Balance as of period end
2016-12-319.84Mn/a2018-03-29, Balance as of period end